Hyponatremia and hypernatremia: Disorders of water balance

Journal of Association of Physicians of India

Volumn 56, Issue DEC., 2008, Pages 956-964

  Agrawal, V ^a   Agarwal, M ^a   Joshi, Shashank R ^b   Ghosh, A K ^c  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Dr Joshi's Imaging Clinic Mumbai   (India)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIURETIC AGENT; SODIUM CHLORIDE; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

DRUG ANTAGONISM; ELECTROLYTE BALANCE; FLUID THERAPY; HUMAN; HYPERNATREMIA; HYPONATREMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SCHWARTZ BARTTER SYNDROME;

ANTIDIURETIC AGENTS; FLUID THERAPY; HUMANS; HYPERNATREMIA; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; RECEPTORS, VASOPRESSIN; SODIUM CHLORIDE; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 57349132456     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Madias NE, Adrogue HJ. Hypo-hypernatraemia: disorders of water balance. In: Davidson AM, Cameron JS, Grünfeld J-P, et al. (eds), Oxford Textbook of Clinical Nephrology, 3rd edn. Oxford University Press, 2005, pp. 213-29.
2. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis 2008; 52 (1) : 144-53.
3. Gennari FJ. Hypo-hypernatraemia: disorders of water balance. In: Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology, 2nd Edition. Oxford University Press, Oxford, New York, Tokyo: 1998: 175-89.
4. Asadollahi K, Beeching N, Gill G. Hyponatraemia as a risk factor for hospital mortality. QJM 2006;99(12):877-80.
5. Rose BD, Black RM (eds): Clinical Problems in Nephrology, ed 1. Boston, Little, Brown, 1996, pp 3-17.
6. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-72.
7. Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med 2006;119(7 Suppl 1):S21-9.
8. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS. Hyponatremia among runners in the Boston Marathon. N Engl J Med 2005;352(15):1550-6.
9. Robertson GL.Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 2006;119(7 Suppl 1): S36-42
10. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342(21):1581-9.
11. Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med 2007;120(8):653-8.
12. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2007;2:1110-7.
13. Liamis G, Kalogirou M, Saugos V, Elisaf M.Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 2006;2(6):1564-9.
14. Nguyen MK, Kurtz I. Analysis of current formulas used for treatment of the dysnatremias. Clin Exp Nephrol 2004;8:12-16.
15. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008;371(9624):1624-32.
16. Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 1996;124:197-203.
17. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007;50:952-7.
18. Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med 2000;342:1493-9.
19. Lindner G, Schwarz C, Kneidinger N, Kramer L, Oberbauer R, Druml W. Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients. Nephrol Dial Transplant 2008; 23:3501-8.